HOME >> BIOLOGY >> NEWS
T cell killing in ADA-SCID

Although many different molecular defects can lead to immunodeficiency, mutations in the adenosine deaminase (ADA) gene were the first identified lesions that cause severe combined immunodeficiency (SCID), affecting both B and T cell development. Despite this long history, the cellular events that lead to the death of lymphocytes in children with diseases of purine metabolism, such as ADA-SCID, have never been clear. ADA carries out a crucial step in the catabolism of adenosine and dATP. Because both of these molecules(the former a well known extracellular signaling molecule, and the latter a cytotoxic compound--at least when it is found at levels in excess of the usual cellular reserves for deoxynucleotides) accumulate in the ADA-deficient thymus, Apasov and coworkers have examined T cell development in youn Ada-/- mice. Here they describe events at the stage when CD4/CD8 double negative T cells would normally undergo positive selection. Apasov et al. show that T cell receptor activation in Ada-/- lymphocytes is inhibited by exogenous adenosine, and they suggest a model in which excess extracellular adenosine and toxic levels of dATP cooperate to promote apoptosis of developing T cells. The B cell and NK cell defects seen in these animals were not addressed in this work, but it may be interesting to examine the fate of these cells in ADA deficient animals, considering that a related metabolic disorder, nucleoside phosphorylase deficiency, leads not to SCID but to a specific loss of T cells.


'"/>

Contact: John Ashkenas
scied@the-jci.org
416-946-7593
Journal of Clinical Investigation
26-Jun-2001


Page: 1

Related biology news :

1. Fire ant killing protozoa found in 120 Texas counties
2. Marine scientists discover nutrient pollution boosts fungi, bacteria killing Caribbean reefs
3. Controversial UK badger killings analyzed by UC Davis expert
4. Human rights in Peru: AAAS analysis doubles previous estimates of killings
5. Researchers discover effective method for killing prostate cancer cells
6. Redheaded women respond better to painkilling drug
7. Cat parasite killing otters; Michigans perch pressured; HACCP for medicine
8. Scientists find new way to assess where cotton-killing pests develop
9. Ozone produced by antibodies during bacterial killing and in inflammation
10. Scientists sequence genome of rice-killing fungus
11. UF research: methyl bromide more effective, economical for killing anthrax

Post Your Comments:
*Name:
*Comment:
*Email:


(Date:11/7/2018)... ... November 07, 2018 , ... Features such as 24/7 phone ... changes all contribute to client retention and referral business in the clinical trial ... services provider says 80 percent of its new business is attributed to referrals ...
(Date:11/7/2018)... Utah and BOSTON, Mass. (PRWEB) , ... November ... ... in delivering cloud-based enterprise-class unified communications and collaboration solutions, announced today a modernized ... white label exclusive website and a newly established reseller administrative control ...
(Date:11/7/2018)... ... November 07, 2018 , ... The awards were presented ... science industry. The event was attended by 150 industry executives from leading life ... drug discovery. The winners were determined by responses to an online ballot completed ...
Breaking Biology News(10 mins):
(Date:10/31/2018)... POWAY, Calif. (PRWEB) , ... October 30, 2018 , ... Pippa Rose is a young ... was around one year old, Pippa suffered a partial tear to the cruciate ligament in ... unable to run or go on walks. Kinsley reported that it broke her heart ...
(Date:10/25/2018)... ... October 24, 2018 , ... To prepare for radiological and nuclear ... work Argentum Medical, LLC to repurpose its commercial Silverlon ® technology ... the privately held company has been awarded a three-year, $8.4 million contract with the ...
(Date:10/24/2018)... SAN JOSE, Calif. (PRWEB) , ... October 23, ... ... and cell biology technologies, today announced a new, exciting brand for its recently ... technology platform with Molecular Devices’ Biologics Biotherapeutics portfolio of products, and henceforth will ...
(Date:10/17/2018)... ... October 17, 2018 , ... ... and his associate, Dr. Michael Kang, are offering current and new patients the ... results thanks to the emerging, proven treatment technology known as Piezosurgery® . ...
Breaking Biology Technology:
Cached News: